$CALC 4 SEC Filings

Filed On	Filing
05 Oct 2026	Form 4: Guerard Frederic, Director Granted 20,000 Director Stock Option (Right to Buy)
05 Oct 2026	Form 4: Glicklich Alan, Director Granted 20,000 Director Stock Option (Right to Buy)
05 Oct 2026	Form 4: Zaytsev Evgeny, Director Granted 20,000 Director Stock Option (Right to Buy)
05 Oct 2026	Form 4: Shaw Allan, Director Granted 20,000 Director Stock Option (Right to Buy)
05 Oct 2026	Form 4: Wilson Robert N, Director Granted 20,000 Director Stock Option (Right to Buy)
28 Sep 2026	Form 4: Stauderman Kenneth A., Chief Scientific Officer Granted 180,000 Employee Stock Option (Right to Buy)
28 Sep 2026	Form 4: Hebbar Sudarshan, Chief Medical Officer Granted 180,000 Employee Stock Option (Right to Buy)
28 Sep 2026	Form 4: Bardin Stephen, Chief Financial Officer Granted 190,000 Employee Stock Option (Right to Buy)
28 Sep 2026	Form 4: Leheny A. Rachel, Director Granted 360,000 Employee Stock Option (Right to Buy)
24 Aug 2026	Form 4: Alafi Capital Co Llc, 10% owner Granted 3,529,192 Series A Warrants · Granted 3,529,192 Series B Warrants
21 Aug 2026	Form 4: Shaw Allan, Director Granted 10,000 Director Stock Option (Right to Buy)
21 Aug 2026	Form 4: Glicklich Alan, Director Granted 10,000 Director Stock Option (Right to Buy)
21 Aug 2026	Form 4: Guerard Frederic, Director Granted 10,000 Director Stock Option (Right to Buy)
21 Aug 2026	Form 4: Zaytsev Evgeny, Director Granted 2,900,534 Warrant · Granted 10,000 Director Stock Option (Right to Buy)
21 Aug 2026	Form 4: Wilson Robert N, Director Granted 2,365,242 Warrant · Granted 10,000 Director Stock Option (Right to Buy)
21 Aug 2026	Form 4: Hebbar Sudarshan, Chief Medical Officer Granted 248,972 Warrant
21 Aug 2026	Form 4: Roberts Eric W, Director Granted 373,458 Warrant
21 Aug 2026	Form 4: Leheny A. Rachel, Director Granted 373,458 Warrant
07 Jul 2026	Form 4: Zaytsev Evgeny, Director Granted 20,000 Director Stock Option (Right to Buy)
29 Jun 2026	Form 4: Roberts Eric W, Director Received 186,729 shares as a grant or award ($150K)

Comments